Plus   Neg

CytomX Therapeutics Inc. (CTMX) Jumped To A New High On Amgen Collaboration

CytomX Therapeutics Inc. (CTMX) announced after the bell Tuesday that it has entered into a strategic collaboration with Amgen (AMGN) in immuno-oncology.

CytomX Therapeutics gapped open sharply higher Wednesday, but pared its gains in early trade, before settling into a range. Shares finished up by 4.09 at $23.09 on the highest volume of the year. The stock surged to a new high for the year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Follow RTT